Today the American Cancer Society and its advocacy affiliate, the American Cancer Society Cancer Action Network (ACS CAN), submitted comments to HHS and the FDA in response to the proposed rule to modify the Common Rule, which governs the treatment of human subjects in clinical trials funded by more than